Patents by Inventor Hiroshi Takenaka

Hiroshi Takenaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12093851
    Abstract: A matching system that matches a first vehicle requiring substitution when being at least either loaded into or unloaded from a parking place and a remote driver driving the first vehicle as a substitute through remote operation includes a terminal and a server. The terminal transmits substitution request information to the server. The server that has received the request information transmits waiting time information to the terminal. The terminal notifies a user or a staff of the received waiting time information, accepts a waiting time information approval or additional fee payment instructions, and settles the additional fee through cooperation with the server, upon receiving the payment instructions. The server changes the turn of the first vehicle in a queue for the remote operation service such that the first vehicle is prioritized more than a second vehicle that has not paid the additional fee, upon completing the additional fee settlement.
    Type: Grant
    Filed: June 7, 2022
    Date of Patent: September 17, 2024
    Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Toru Nishitani, Rio Suda, Hiroshi Yonenaga, Hidekazu Sasaki, Tatsushi Takenaka, Shun Ota, Akihiro Kusumoto
  • Publication number: 20240239816
    Abstract: Provided are new compounds that can have the property of being specifically taken up into cancer cells. In the present invention, novel 4-borono-phenylalanine derivatives, borono-phenylalanine derivatives having a heterocyclic skeleton, borono-phenylalanine derivatives having a fused ring structure, or pharmaceutically acceptable salts thereof are prepared. These compounds have the property of being taken up specifically by LAT1 and thus easily taken up specifically by cancer cells in the evaluation of LAT1 and LAT2 selective uptake, and can be conveniently used for neutron capture therapy and the like. A typical example is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 20, 2022
    Publication date: July 18, 2024
    Inventors: Yusuke MURATA, Hiroshi TAKENAKA, Yoichiro OHTA, Aya SUDANI, Miki ISHIMURA, Kensuke SUZUKI, Hiroyuki KAI
  • Publication number: 20240017785
    Abstract: A fuel tank includes: a fuel tank main body that stores fuel; and an oil filler port, in which an opening that penetrates the fuel tank main body is provided, a plate member that closes the opening is welded to the fuel tank main body, a strength of the plate member is higher than a strength of the fuel tank main body, and the oil filler port is provided in the plate member.
    Type: Application
    Filed: June 10, 2021
    Publication date: January 18, 2024
    Inventors: Hiroshi Takenaka, Daisuke Yamaguchi, Yasuo Shinde
  • Publication number: 20230416280
    Abstract: A method for producing 4-borono-L-phenylalanine and its intermediates is provided. The method is for producing a substituted phenyl compound represented by formula (II) from a substituted phenyl compound represented by formula (I). The method comprises a first step in which the compound represented by formula (I) reacts with a linear or branched C1-C10 alkylmagnesium halide in the presence of a metal halide; and a second step in which a boronic acid ester or boronic acid amide reacts with the compound obtained in said first step. The method also can comprise a step of deprotecting the compound of formula (II) obtained in the second step.
    Type: Application
    Filed: November 8, 2021
    Publication date: December 28, 2023
    Inventors: Yusuke MURATA, Yoichiro OHTA, Hiroshi TAKENAKA, Kensuke SUZUKI
  • Patent number: 11758309
    Abstract: An antenna includes: a dielectric substrate; a conductive plane formed on a back surface of the dielectric substrate; a radiating element having a linear shape and formed on a front surface of the dielectric substrate; a shorting pin connecting one end of the radiating element to the conductive plane; and a power supply pin that is connected to the radiating element, at a point a predetermined distance away from the one end to which the shorting pin is connected, through a hole provided in the conductive plane, and that supplies a transmission signal to the radiating element. A radio wave is emitted from the radiating element.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: September 12, 2023
    Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Thanh Dinh Le, Kenichi Ichinose, Hiroshi Yoshimoto, Katsumi Matsuoka, Hiroshi Takenaka, Hironori Doi
  • Publication number: 20230235291
    Abstract: This invention relates to a tissue construct comprising a core portion having a recess and composed of fibrous connective tissue, and loose fibrous somatic stem cell-accumulated tissue comprising type III collagen and somatic stem cells which is formed in the recess; a device for producing the same; and a method for collecting somatic stem cells from the tissue construct.
    Type: Application
    Filed: May 28, 2021
    Publication date: July 27, 2023
    Applicant: BIOTUBE CO., LTD.
    Inventors: Yasuhide NAKAYAMA, Yasushi SATO, Ryosuke IWAI, Masanori FUKUSHIMA, Hiroshi TAKENAKA
  • Publication number: 20230007911
    Abstract: An antenna includes: a dielectric substrate; a conductive plane formed on a back surface of the dielectric substrate; a radiating element having a linear shape and formed on a front surface of the dielectric substrate; a shorting pin connecting one end of the radiating element to the conductive plane; and a power supply pin that is connected to the radiating element, at a point a predetermined distance away from the one end to which the shorting pin is connected, through a hole provided in the conductive plane, and that supplies a transmission signal to the radiating element. A radio wave is emitted from the radiating element.
    Type: Application
    Filed: May 6, 2022
    Publication date: January 12, 2023
    Inventors: Thanh Dinh LE, Kenichi ICHINOSE, Hiroshi YOSHIMOTO, Katsumi MATSUOKA, Hiroshi TAKENAKA, Hironori DOI
  • Patent number: 10344042
    Abstract: The present invention involves preparing compounds represented by the following formula: from a compound of the following formula: In these formulae: R1 represents a Br group, an iodine group, a Cl group, an NO2 group, or an NH2 group; R2 represents a halogen group, an NO2 group, an NH2 group, Sn(R6)3, N?N—NR7R8, OSO2R9, N R10R11, phenyliodonium, a heterocyclic group iodine, boric acid, or a borate ester; R30 represents a protective group PG1; R40 or R50 represent hydrogen, a protective group PG2, or C6H5(C6H5)C?N, in which NR40R50 are together.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: July 9, 2019
    Assignees: Stella Pharma Corporation, Osaka Prefecture University Public Corporation
    Inventors: Hiroshi Takenaka, Yoichiro Ohta, Yusuke Taguchi, Sayuri Ueda, Yuko Ishino, Tomohiro Yoshikawa, Hideki Nakashima, Kohki Uehara, Mitsunori Kirihata
  • Patent number: 10133737
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for transforming text strings. In general, one aspect of the subject matter described in this specification can be embodied in methods that include the actions of receiving input string having a plurality of terms, the input string being in a first form; transforming the input string from the first form to a second form including: applying one or more rules to the input string to identify one or more terms for translation, the one or more identified terms being fewer than the plurality of terms, translating the identified one or more terms to one or more translated terms in the second form, and transliterating the remaining terms of the plurality of terms into transliterated terms in the second form; and concatenating the translated and transliterated terms to form a hybrid output string in the second form.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: November 20, 2018
    Assignee: GOOGLE LLC
    Inventors: Sascha B Brawer, Martin Jansche, Richard Sproat, Hiroshi Takenaka, Yui Terashima
  • Patent number: 10005794
    Abstract: The present invention involves preparing compounds represented by the formula. (In the formula: R1 represents a Br group, an iodine group, a Cl group, an NO2 group, or an NH2 group; R2 represents a halogen group, an NO2 group, an NH2 group, Sn(R6)3, N?N—NR7R8, OSO2R9, NR10R11, phenyliodonium, a heterocyclic group iodine, boric acid, or a borate ester; R30 represents a protective group PG1; R40 or R50 represent hydrogen, a protective group PG2, or C6H5(C6H5)C?N, wherein NR40R50 are together.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: June 26, 2018
    Assignees: STELLA PHARMA CORPORATION, OSAKA PREFECTURE UNIVERSITY PUBLIC CORPORATION
    Inventors: Hiroshi Takenaka, Yoichiro Ohta, Yusuke Taguchi, Sayuri Ueda, Yuko Ishino, Tomohiro Yoshikawa, Hideki Nakashima, Kohki Uehara, Mitsunori Kirihata
  • Patent number: 9815855
    Abstract: 18F-labeled 4-boronophenylalanine (BPA) can be produced by preparing and further processing a precursor of 18F-labeled BPA represented by the following formula: in which R1 represents a bromo group, an iodo group, a fluoro group, a diazaborinane derivative, BX3? or BX3?M+ (wherein X represents a halogen atom; and M+ represents a monovalent monoatomic cation, a polyatomic cation or a complex cation).
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: November 14, 2017
    Assignees: Stella Pharma Corporation, Osaka Prefecture University Public Corporation
    Inventors: Hiroshi Takenaka, Yoichiro Ohta, Yusuke Taguchi, Sayuri Ueda, Yuko Ishino, Tomohiro Yoshikawa, Hideki Nakashima, Kohki Uehara, Mitsunori Kirihata
  • Publication number: 20170283441
    Abstract: The present invention involves preparing compounds represented by the following formula: from a compound of the following formula: In these formulae: R1 represents a Br group, an iodine group, a Cl group, an NO2 group, or an NH2 group; R2 represents a halogen group, an NO2 group, an NH2 group, Sn(R6)3, N?N—NR7R8, OSO2R9, N R10R11, phenyliodonium, a heterocyclic group iodine, boric acid, or a borate ester; R30 represents a protective group PG1; R40 or R50 represent hydrogen, a protective group PG2, or C6H5(C6H5)C?N, in which NR40R50 are together.
    Type: Application
    Filed: June 16, 2017
    Publication date: October 5, 2017
    Inventors: Hiroshi Takenaka, Yoichiro Ohta, Yusuke Taguchi, Sayuri Ueda, Yuko Ishino, Tomohiro Yoshikawa, Hideki Nakashima, Kohki Uehara, Mitsunori Kirihata
  • Publication number: 20170015684
    Abstract: 18F-labeled 4-boronophenylalanine (BPA) can be produced by preparing and further processing a precursor of 18F-labeled BPA represented by the following formula: in which R1 represents a bromo group, an iodo group, a fluoro group, a diazaborinane derivative, BX3? or BX3?M+ (wherein X represents a halogen atom; and M+ represents a monovalent monoatomic cation, a polyatomic cation or a complex cation).
    Type: Application
    Filed: January 28, 2015
    Publication date: January 19, 2017
    Inventors: Hiroshi TAKENAKA, Yoichiro OHTA, Yusuke TAGUCHI, Sayuri UEDA, Yuko ISHINO, Tomohiro YOSHIKAWA, Hideki NAKASHIMA, Kohki UEHARA, Mitsunori KIRIHATA
  • Publication number: 20160311836
    Abstract: The present invention involves preparing compounds represented by the formula. (In the formula: R1 represents a Br group, an iodine group, a Cl group, an NO2 group, or an NH2 group; R2 represents a halogen group, an NO2 group, an NH2 group, Sn(R6)3, N?N—NR7R8, OSO2R9, NR10R11, phenyliodonium, a heterocyclic group iodine, boric acid, or a borate ester; R30 represents a protective group PG1; R40 or R50 represent hydrogen, a protective group PG2, or C6H5(C6H5)C?N, wherein NR40R50 are together.
    Type: Application
    Filed: December 16, 2014
    Publication date: October 27, 2016
    Inventors: Hiroshi Takenaka, Yoichiro Ohta, Yusuke Taguchi, Sayuri Ueda, Yuko Ishino, Tomohiro Yoshikawa, Hideki Nakashima, Kohki Uehara, Mitsunori Kirihata
  • Patent number: 9409926
    Abstract: Provided are: a novel chiral 4-boronophenylalanine (BPA) derivative; a method for producing the derivative; and a method for producing 18F-2-fluoro-4-borono-L-phenylalanine (18F-labeled BPA; 18F-BPA) using the derivative. A compound represented by formula (1) is prepared. In the formula, R represents BR3R4, BX3? or BX3?M+ (wherein X represents a halogen atom, and M+ represents a monovalent monoatomic cation, a polyatomic cation or a complex cation); R1 represents a hydrogen atom or a protecting group PG1; R2 represents a hydrogen atom or a protecting group PG2; R3 and R4 independently represent OH, or R3, R4 and B together form a ring that serves as a protecting group; and Y represents a halogen atom, NO2, NH2, Sn(R6)3, N?N—NR7R8, OSO2R9, NR10R11, a substituted or unsubstituted phenyliodo group or a substituted or unsubstituted heterocyclic iodo group. The compound is reacted with a fluorination reagent to prepare 18F-labeled BPA.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: August 9, 2016
    Assignee: STELLA PHARMA CORPORATION; OSAKA PREFECTURE UNIVERSITY PUBLIC CORPORATION
    Inventors: Hiroshi Takenaka, Yoichiro Ohta, Yusuke Taguchi, Sayuri Ueda, Yuko Ishino, Hideki Nakashima, Kohki Uehara, Mitsunori Kirihata
  • Publication number: 20160032533
    Abstract: The present invention relates to a decorated readily formable paper suitable for an in-mold decorated fibrous molded article and the invention relates also to a method of manufacturing an in-mold decorated fibrous molded article. Provided are a decorated readily formable paper which suffers no ink running during molding and which also has superior friction resistance and a method of manufacturing an in-mold decorated fibrous molded article using such paper. A decorated readily formable paper 11 includes a readily formable paper 1, a pattern layer 8 formed on one face of the readily formable paper 1, a varnish layer 9 formed on the readily formable paper 1 and the pattern layer 8, and a protection layer 10 formed on the varnish layer 9. The pattern layer 8, the varnish layer 9 and the protection layer 10 are printed layers 2.
    Type: Application
    Filed: November 8, 2013
    Publication date: February 4, 2016
    Inventors: Tomoyuki Ohnishi, Hiroshi Takenaka
  • Publication number: 20150329564
    Abstract: Provided are: a novel chiral 4-boronophenylalanine (BPA) derivative; a method for producing the derivative; and a method for producing 18F-2-fluoro-4-borono-L-phenylalanine (18F-labeled BPA; 18F-BPA) using the derivative. A compound represented by formula (1) is prepared. In the formula, R represents BR3R4, BX3? or BX3?M+ (wherein X represents a halogen atom, and M+ represents a monovalent monoatomic cation, a polyatomic cation or a complex cation); R1 represents a hydrogen atom or a protecting group PG1; R2 represents a hydrogen atom or a protecting group PG2; R3 and R4 independently represent OH, or R3, R4 and B together form a ring that serves as a protecting group; and Y represents a halogen atom, NO2, NH2, Sn(R6)3, N?N—NR7R8, OSO2R9, NR10R11, a substituted or unsubstituted phenyliodo group or a substituted or unsubstituted heterocyclic iodo group. The compound is reacted with a fluorination reagent to prepare 18F-labeled BPA.
    Type: Application
    Filed: October 8, 2013
    Publication date: November 19, 2015
    Inventors: Hiroshi TAKENAKA, Yoichiro OHTA, Yusuke TAGUCHI, Sayuri UEDA, Yuko ISHINO, Hideki NAKASHIMA, Kohki UEHARA, Mitsunori KIRIHATA
  • Patent number: 8907128
    Abstract: The purpose of the present invention is to provide a novel boron-containing compound utilizable in BNCT and so on and a process for preparing same. According to the process, a boron compounds having an amino acid skeleton containing cyclo-type rings or a pharmaceutically acceptable salt thereof is prepared, said boron compound being represented by general formula (I) [wherein l is an integer of 1 to 6; m is 0, 1, or 2; and n is 0, 1 or 2].
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: December 9, 2014
    Assignee: Stella Pharma Corporation
    Inventors: Mitsunori Kirihata, Yoshihide Hattori, Kohki Uehara, Hiroshi Takenaka
  • Publication number: 20140163952
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for transforming text strings. In general, one aspect of the subject matter described in this specification can be embodied in methods that include the actions of receiving input string having a plurality of terms, the input string being in a first form; transforming the input string from the first form to a second form including: applying one or more rules to the input string to identify one or more terms for translation, the one or more identified terms being fewer than the plurality of terms, translating the identified one or more terms to one or more translated terms in the second form, and transliterating the remaining terms of the plurality of terms into transliterated terms in the second form; and concatenating the translated and transliterated terms to form a hybrid output string in the second form.
    Type: Application
    Filed: August 26, 2011
    Publication date: June 12, 2014
    Inventors: Sascha B Brawer, Martin Jansche, Richard Sproat, Hiroshi Takenaka, Yui Terashima
  • Patent number: 8568967
    Abstract: A method is provided for diagnosis of the severity of a condition in an eosinophilic inflammatory disease such as nasal polyp and for prediction of the recurrence of the disease.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: October 29, 2013
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Yoshihiro Urade, Naomi Eguchi, Kosuke Aritake, Sawako Hyo, Hiroshi Takenaka, Ryo Kawata